Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Amphibian may hold key to curing cirrhosis
The liver of the Siphonops annulatus could help to cure cirrhosis in humans.

Unique liver cells break down the protein collagen

A South American amphibian could hold the key to curing cirrhosis, according to new research.

Researchers found the liver of Siphonops annulatus contains unique liver cells - known as melanomacrophages - which can remove and break down the protein collagen. In turn, this helps to minimise unwanted inflammation and reduce scar tissue which can lead to cirrhosis.

Study author Dr Augusto Coppi from the University of Surrey said: “The liver function of this amphibian, Siphonops annulatus, may provide us with a unique opportunity to solve one of the most devastating illnesses of the liver.

“We do need further in-depth investigations into how this discovery can be translated into humans, but it may have the potential to alter how we view and treat this disease.”

Cirrhosis occurs in response to liver damage. Hepatitis, chronic alcoholism or other harmful substances can all prompt the response of self-repair in the liver, which manifests as a high production of collagen and scar tissue.

As the condition progresses, liver functions such as cleaning blood become difficult. Several treatment strategies for cirrhosis have been attempted across the world including delaying or removing the underlying stimulus that causes scar tissue to form.

Dr Robson Gutierre from the Federal University of Sao Paulo said: “The ability this species has to break down its natural defences could also provide insight into immunity tolerance, a mechanism by which the liver can minimise unwanted inflammations.

"|mmunity tolerance can be studied in this species because they produce pro-inflammatory cells in the hematopoietic liver throughout its whole life, without developing chronic inflammations.”
 
The study, Melanomacrophage functions in the liver of the caecilian Siphonops annulatus, is published in The Journal of Anatomy.

Image (C) Andreas Schlüter

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.